Operating Margin of Lyra Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lyra Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Lyra Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -5885%, a 15% increase year-over-year.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2024 was -6281%, a 46% decline from 2023.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2023 was -4308%, a 4.3% decline from 2022.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2022 was -4131%, a 73% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Lyra Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -5885% +1009% +15% 01 Jul 2025 30 Sep 2025
Q2 2025 -5392% +421% +7.2% 01 Apr 2025 30 Jun 2025
Q1 2025 -6892% -2527% -58% 01 Jan 2025 31 Mar 2025
Q4 2024 -6281% -1973% -46% 01 Oct 2024 31 Dec 2024
Q3 2024 -6894% -2271% -49% 01 Jul 2024 30 Sep 2024
Q2 2024 -5813% -660% -13% 01 Apr 2024 30 Jun 2024
Q1 2024 -4365% +363% +7.7% 01 Jan 2024 31 Mar 2024
Q4 2023 -4308% -177% -4.3% 01 Oct 2023 31 Dec 2023
Q3 2023 -4624% 01 Jul 2023 30 Sep 2023
Q2 2023 -5153% 01 Apr 2023 30 Jun 2023
Q1 2023 -4728% 01 Jan 2023 31 Mar 2023
Q4 2022 -4131% 01 Oct 2022 31 Dec 2022

Lyra Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -6281% -1973% -46% 01 Jan 2024 31 Dec 2024
2023 -4308% -177% -4.3% 01 Jan 2023 31 Dec 2023
2022 -4131% +11172% +73% 01 Jan 2022 31 Dec 2022
2021 -15304% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.